未登录

W

Wayne Macfadden

jazz pharmaceuticals

H指数:4

被引数:55

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Increased Risk of New-Onset Hypertension in Patients With Narcolepsy Initiating Sodium Oxybate: A Real-World Study

起始羟丁酸钠的发作性睡病患者新发高血压的风险增加: 一项真实世界研究

MAYO CLINIC PROCEEDINGS

IF6.7

2024-11-011

OAAI

Effectiveness and optimization of low-sodium oxybate in participants with narcolepsy switching from a high-sodium oxybate: data from the Substitution of Equal Grams of Uninterrupted Xyrem to Xywav study

JOURNAL OF CLINICAL SLEEP MEDICINE

IF2.9

2024-09-010

PRE

Effectiveness and tolerability in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study (vol 109, pg 65, 2023)

IF3.4

2024-07-010

PRE

Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary (vol 12, pg 1805, 2023)

NEUROLOGY AND THERAPY

IF4.8

2024-06-240

OAAI

SUPPORTING PATIENT SAFETY WITH OXYBATE THERAPY: A SURVEY OF PATIENTS AND PRESCRIBERS

IF4.9

2024-04-200

PRE

PATIENT-CENTRIC DESIGN: INCORPORATING PATIENT INPUT INTO A CLINICAL STUDY OF IDIOPATHIC HYPERSOMNIA AND NARCOLEPSY

IF4.9

2024-04-200

PRE

Dosing and transition characteristics in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study

IF3.4

2024-01-012

OAAI

Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary

NEUROLOGY AND THERAPY

IF4.8

2023-09-276

OAAI

Effectiveness and tolerability in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study

IF3.4

2023-09-018

OAAI

Effects of Low-Sodium Oxybate on 24-Hour Total Sleep Time: Data From a Phase 3 Clinical Study in Adults With Idiopathic Hypersomnia

IF8.5

2023-04-250

PRE

Effectiveness and Optimization of Low-Sodium Oxybate in Participants With Narcolepsy Switching From High-Sodium Oxybate: Interim Data from the Substitution of Equal Grams of Uninterrupted Xyrem to Xywav (SEGUE) Study

IF8.5

2023-04-250

PRE

Preclinical Pharmacology of Solriamfetol: Potential Mechanisms for Wake Promotion

IF4.1

2023-04-140

OA

Once-nightly sodium oxybate (FT218) in the treatment of narcolepsy: a letter to the editor commenting on the recent publication by C. Kushida et al.

IF4.9

2022-06-130

OAAI